Ferriz

Quick links to important sections

Ferriz

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ferriz

Property Description
Active Ingredient Iron(III) fluoride (FeF3)
Pharmacological Class Fluoride Therapy Agent / Mineral Supplement
Origin Synthetic Inorganic Compound
High-Level Form Varies (e.g., Solution, Powder)
General Purpose Enhancing tooth structure and resistance to decay

What Type of Medicine is Ferriz? (Identity and Classification)

Ferriz is a proprietary medicinal preparation classified within the functional category of a Fluoride Therapy Agent, a specialized type of Mineral Supplement used for its chemical effect on mineralized tissues. The primary purpose of such agents is to deliver the fluoride ion (F^-) to support the prevention of dental decay, which is a foundational use of this agent type. Ferriz is a Single Active Ingredient preparation, and depending on its final form, it may be designed for either Topical (surface) or Oral (ingested) administration.

Composition and Origin: Is Ferriz a Natural or Synthetic Compound?

The chemical foundation of Ferriz is the active ingredient Iron(III) fluoride (FeF3), also referred to as Ferric fluoride or Iron trifluoride. This substance is a Synthetic Inorganic Compound, meaning it is manufactured through defined chemical processes rather than being directly harvested from biological sources. As a Ferric salt, the compound uniquely contains iron in its trivalent state (Fe^3+) alongside the active fluoride component. The high-level composition comprises the FeF3 active agent mixed with a varying base or vehicle, such as an Aqueous solution or an excipient powder, depending on the final pharmaceutical preparation.

What is the General Purpose of Taking Ferriz? (High-Level Benefit)

The general function of Ferriz is to enhance the structural integrity of teeth by reinforcing and protecting the tooth enamel. Its use aligns with the general therapeutic purpose of all fluoride agents: to facilitate the essential chemical process of enamel remineralization. This action helps to make the mineralized structure of the teeth more resistant to dissolution by acids, which are the main biological cause of decay. By reinforcing the enamel, the medicine supports the natural defense of the teeth against deterioration.

Regulatory References

  1. MedlinePlus Fluoride Information

What side effects are possible with Ferriz?

Possible Side Effects and Safety Information

The safety profile of Ferriz, an Iron(III) fluoride agent, is structured around adverse reactions affecting specific organ systems and risks associated with exposure levels, as documented in official regulatory sources for fluoride compounds. The safety summary focuses on localized effects from use and the systemic risks associated with ingestion.


Documented Adverse Reactions

Adverse reactions are classified by the system they affect, primarily involving the Gastrointestinal Disorders class. Documented effects include nausea, vomiting, abdominal pain, and diarrhea, often associated with systemic exposure. Localized effects in the mouth, such as a burning sensation or oral mucosal exfoliation, have also been noted. Hypersensitivity reactions (e.g., rash) are classified as Rare in regulatory documents for this pharmacological class.

Serious Adverse Reactions and Systemic Risk

Acute Systemic Toxicity is the most serious documented risk, associated with massive, accidental ingestion, which may lead to severe systemic effects including convulsions. The safety profile also highlights the long-term, dose-dependent risk of Fluorosis. Dental Fluorosis, characterized by changes in tooth appearance (staining or mottling), results from excessive cumulative exposure during the early years of tooth development. Continued excessive chronic intake is associated with Skeletal Fluorosis, involving bone changes.


Population-Specific Safety Considerations

Official safety documents define specific constraints for certain groups. Due to the high risk of dental fluorosis, particular caution and restrictions are mandated for the Pediatric Population, specifically children under the age of three. Additionally, patients with Renal Impairment (impaired kidney function) require caution, as the body's ability to excrete fluoride may be diminished, potentially increasing the risk of systemic toxicity.

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines the officially documented manifestations and required emergency actions for Ferriz overdose, based on government regulatory and authoritative clinical sources.

Overdose with Ferriz (Iron(III) fluoride) is classified as potentially severe and life-threatening. Manifestations typically begin with acute Gastrointestinal effects, including protracted vomiting (which may be bloody/hematemesis), severe abdominal pain, and profuse diarrhea. This can progress rapidly to systemic toxicity.

Officially documented severe outcomes include a rapid onset of Hypotension, leading to Shock and Cardiac Arrest. Toxicity can cause severe physiological disturbances such as Metabolic Acidosis and critical Hypocalcemia (low blood calcium), along with delayed acute organ damage like Liver and Renal failure.

Severe Manifestations Emergency Required Action
Shock, Seizures, Coma, Cardiac Arrest Seek immediate medical attention for any suspected overdose.
Protracted Vomiting/Diarrhea Contact a Poison Control Center or emergency services immediately.

Immediate medical attention and hospitalization are required for all suspected symptomatic overdose cases. Management involves symptomatic and supportive treatment, continuous monitoring of vital signs, and specific laboratory studies, including Serum Iron Levels and Electrolyte checks. The use of component-specific interventions, such as Deferoxamine for iron toxicity or intravenous Calcium for severe hypocalcemia, is documented as part of supportive care. Acute iron toxicity is explicitly noted as a potential cause of fatal poisoning in children younger than age 5.

Therapeutic Uses of Ferriz

What Ferriz Treats: Main Uses and Benefits

Ferriz is commonly used to help address symptoms related to organ-specific functional stress, which may include conditions characterized by periods of heightened symptoms related to dental decay risk. Fluoride is considered relevant in conditions where symptoms may intensify temporarily.

The medication is applied across domains where additional symptomatic support is needed, such as when addressing initial-stage decay lesions or when patients experience symptoms related to inflammatory or irritative states due to acid exposure. It supports the patient during difficult episodes by easing distress and contributing to improved day-to-day comfort. Used within therapeutic areas involving heightened responses, this may be part of symptomatic management.

“Ferriz is applied when symptoms create noticeable physiological strain and may assist with maintaining functional stability.”


Quick Fact: Relief for Early Lesions The medicine is relevant for managing symptoms that interfere with daily comfort, which helps ease the overall symptom burden.

Regulatory References

  1. National Institute of Dental and Craniofacial Research (NIDCR) overview

Eligibility and Restrictions for Use

Who can and cannot use Ferriz?

Eligibility for Ferriz (Iron(III) fluoride) is strictly defined by regulatory authorities and depends on the user's age, iron status, and existing conditions. The medicine is generally approved for use in adults and adolescents, but specific populations are prohibited from use or require strict restriction.


Populations For Whom Use is Contraindicated

Ferriz is contraindicated (must not be used) in populations with specific pre-existing conditions as documented in regulatory labeling:

Contraindication Category Examples of Prohibited Conditions
Iron Overload Risk Hemochromatosis, Hemosiderosis, Repeated Blood Transfusions
Gastrointestinal Disease Active Peptic Ulceration, Ulcerative Colitis, Regional Enteritis
Hypersensitivity Known allergy to fluoride or any component

Age-Related Eligibility and Restrictions

Use is prohibited for children under the age of 6 years due to the officially documented risk of developing dental fluorosis from ingestion. Pediatric patients aged 6 to 12 years require specific supervision to ensure the product is not swallowed.

Condition-Specific Limitations

Use is not recommended for patients with severe kidney problems (renal impairment), as fluoride clearance is compromised. During pregnancy and lactation, regulatory classification advises restricted use, or use with caution, due to limited data regarding systemic exposure.

What should I know about interactions with other medicines?

Ferriz Interactions with other medicines and products

Ferriz (deferiprone) is known to interact with certain substance categories, primarily affecting absorption and increasing the risk of specific adverse effects. Understanding these interactions is critical for safe use.

Interacting Category Nature of Interaction Timing and Restrictions
Drugs Associated with Neutropenia or Agranulocytosis Additive risk of severe blood disorders, including neutropenia and fatal agranulocytosis. Avoid co-administration. If unavoidable, the Absolute Neutrophil Count (ANC) must be closely monitored.
Products Containing Polyvalent Cations (e.g., Iron, Aluminum, Zinc) Reduced absorption of Ferriz due to chelation in the gastrointestinal tract, lowering its effectiveness. Allow at least a 4-hour interval between the administration of Ferriz and these supplements or antacids.
UGT1A6 Inhibitors (e.g., Diclofenac, Probenecid) Potential for altered metabolism of Ferriz, which may increase its plasma concentration. Avoid co-administration.

The most significant clinical interaction involves drugs that increase the risk of neutropenia, requiring strict avoidance or immediate discontinuation if this blood disorder develops. The interaction with polyvalent cations is managed by separating the dosing times to prevent a decrease in the amount of Ferriz absorbed by the body. All other co-administered medicinal products, vitamins, and supplements should be reviewed by a healthcare professional.

Mechanism of Action

Ferriz (Ferric Derisomaltose) is an engineered iron complex designed to deliver bioavailable iron directly to the body's utilization pathways. Its mechanism involves controlled processing primarily within the macrophages of the Reticuloendothelial System (RES).

Upon uptake, the complex dissociates to release Fe^3+ iron. This controlled release limits the presence of non-transferrin-bound iron in the plasma, facilitating efficient binding to the transport protein transferrin for systemic distribution.

Transferrin subsequently transports the iron primarily to the bone marrow, where it is incorporated into the erythropoiesis pathway. Here, the delivered iron acts as a necessary substrate for heme synthesis, thereby supporting the manufacture of hemoglobin. The incorporation of iron into hemoglobin increases the mass of functional hemoglobin, resulting in enhanced oxygen-carrying capacity of the blood.

A portion of the iron is also channeled to the liver and spleen where it is incorporated into the storage protein ferritin. This action restores the storage iron pool, contributing to the body's overall maintenance of iron homeostasis.

Dosage and Administration Information

Ferriz is utilized as a once-daily oral administration, consistent with the use of systemic fluoride agents in dental prophylaxis. The medicine is supplied as either an aqueous oral solution/drops or chewable tablets, intended for use over a continuous, long-term duration corresponding to critical periods of tooth development.


The dosing regimen is not standardized by weight but is procedurally determined based on two main factors: the patient's age and the measured concentration of fluoride ion (F^-) in their primary drinking water source. This method yields three possible daily doses of F^- (e.g., 0.25 mg, 0.5 mg, or 1.0 mg). Use is for pediatric patients from approximately six months up to 16 years of age, and involves documentation of the water's fluoride level.


Administration involves specific steps. Oral drops are measured with the supplied calibrated dropper, while tablets are chewed or dissolved in the mouth prior to swallowing. The dose is taken at bedtime after final oral hygiene. Furthermore, to maximize absorption, the protocol is to avoid ingesting dairy products or other calcium-, aluminum-, or magnesium-containing items for one hour after administration. If a dose is missed, it is taken upon remembering unless the next dose is due, in which case the missed dose is skipped; a double dose is not taken.

Recent Clinical Evidence

Research Evidence Overview for Ferriz (Fluoride Therapy Agent)

Evidence for Preventing Dental Decay (Caries Control)

The extensive research on fluoride agents, which includes compounds like Ferriz (Iron(III) fluoride), includes numerous Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies focused primarily on evaluating the use of fluoride to research changes in the tooth's outer structure and examine findings related to new lesion formation. Studies monitored various populations, with the largest volume of evidence coming from trials involving children and adolescents.

Research monitored data show patterns related to the rate of new lesion formation compared to control groups that did not receive the agent. Furthermore, long-term observational data contributes to understanding patterns related to carious disease observed during periods of widespread fluoride exposure. What remains uncertain is the need for more large-scale RCTs specifically focused on Iron(III) fluoride (FeF3) compared to other common fluoride salts.


Research on Managing Early-Stage Lesions

Research has also explored the use of fluoride agents for findings related to initial-stage decay lesions (non-cavitated white spots). Studies used Controlled Clinical Trials to examine whether fluoride delivery was related to changes in these early lesions, measuring lesion size and mineral content. Research highlights changes measured during the study period; however, the findings were mixed across various studies, with outcomes being inconsistent.

Research provides insight into short-term changes, but there is a lack of consistent, long-term evidence tracking whether the measured changes remain stable over multiple years. Comparative evidence is lacking regarding the long-term functional stability of the measured changes compared to untreated lesions.


What Remains Uncertain in the Research Landscape

Evidence quality varies across studies, and there is limited insight into outcomes beyond traditional measures of decay incidence, such as extended-duration physiological markers or patient-reported measures. Research is ongoing, but the data are still emerging regarding the best way to study these agents across different age groups and risk profiles.

Key Studies & References

  1. National Institute of Dental and Craniofacial Research (NIDCR) - Fluoride Health Information
  2. MedlinePlus - Fluoride (Information on Uses and Classification)

Frequently Asked Questions (FAQ)

Common questions about Ferriz (FAQ)

Q: Does Ferriz have to be taken with food, generally speaking?

Regulatory information generally specifies administration at bedtime and mandates that certain products be avoided for one hour after the dose. To support the absorption of the active ingredient, official instructions state that certain products, such as dairy and items containing calcium, aluminum, or magnesium, should be avoided during this time.

Q: Is Ferriz a prescription-only medicine?

Ingestible products that deliver the fluoride ion, such as Ferriz, are generally classified by public health bodies as prescription drug products. These agents are typically intended for use in pediatric patients who are identified as being at high risk of developing dental decay and whose primary drinking water does not contain an adequate level of fluoride.

Q: How does the mechanism of action of Ferriz differ from standard treatments?

Regulatory descriptions explain the mechanism of action for fluoride agents as primarily promoting the remineralization of tooth enamel, which helps to repair the tooth structure. This action strengthens the enamel and inhibits the process of demineralization that can lead to decay.

Q: How long has Ferriz been available on the market?

While a specific approval date for the compound Iron(III) fluoride is often unavailable in patient documents, regulatory reviews indicate that the class of ingestible fluoride drug products has been documented for use since the 1940s for dental prophylaxis.

Q: What does the drug's safety classification mean in simple terms?

The safety of the medicine is often described using official classifications, such as the FDA's Pregnancy Categories (A, B, C, D, or X), to summarize the risk based on available evidence. These categories provide information on the potential risks of using the drug during pregnancy.

Q: Does alcohol consumption interact with Ferriz?

Alcohol and food interactions are often included in the official product information for this drug class, suggesting a possible interaction that requires professional review. Official regulatory interaction sections for fluoride-containing products may list alcohol consumption as a factor that should be reviewed by a health professional.

Q: Can Ferriz be taken at the same time as other vitamins?

Regulatory documents for drugs in this class often list interactions with supplements that contain polyvalent cations, such as iron or zinc. To support absorption, regulatory documents may recommend separating the administration of Ferriz from these supplements by a specific time interval.

Q: Can over-the-counter pain relievers interact with Ferriz?

Official product information lists interaction categories that may include some over-the-counter (OTC) pain relievers, such as UGT1A6 Inhibitors (e.g., Diclofenac or Probenecid), which may require avoidance. The use of all co-administered medicinal products should be reviewed by a health professional.

Q: Is Ferriz known to cause fatigue or sleepiness?

Fatigue and sleepiness are not routinely listed among the common official adverse reactions in the main safety summaries for Ferriz. The documented adverse effects primarily relate to the gastrointestinal system and local oral effects.

Q: Is the main purpose of Ferriz to raise levels of a specific substance?

The primary purpose of Ferriz, according to official information, is not simply to raise systemic levels of a substance. Its function is to deliver the fluoride ion directly to the tooth enamel to facilitate remineralization and structural enhancement, which is the key action for preventing dental decay.

Q: Can Ferriz affect mood or cause emotional changes?

Official product information for Ferriz focuses on physical side effects such as gastrointestinal and oral reactions. Psychiatric or mood-related adverse effects are not routinely documented as common reactions. Due to a focus on physical effects, any potential connection to mood changes is not routinely documented in the standard product information.

Q: Are there any special considerations for women taking Ferriz?

The specific considerations for women listed in regulatory documents relate to its use during pregnancy and lactation. Official classifications advise using the medicine with caution or restriction in these conditions due to limited available safety data on systemic exposure.

Q: Does Ferriz interact with herbal or natural supplements?

Official interaction sections advise caution with products that contain polyvalent cations, which can be found in some natural and herbal supplements. These interactions may reduce the effectiveness of Ferriz. Official information generally advises that the use of all supplements be reviewed by a healthcare professional.

Q: Why do some people experience headaches when taking Ferriz?

Headaches are not listed as a commonly documented official side effect in the regulatory safety summary for this drug class. The primary adverse reactions reported are generally confined to the digestive system and local oral effects.

Q: Are there official registry studies or post-marketing surveillance for Ferriz?

Regulatory documents confirm that the long-term safety of this class of agents is monitored through processes that include the review of long-term observational data. This type of information gathering is consistent with post-marketing surveillance, where data is collected on drug performance and safety after initial approval.

Q: Is there a maximum amount of time Ferriz is intended to be used?

Official guidance defines the duration of treatment as continuous and long-term, specifically corresponding to the critical periods of tooth development. This means use is generally intended to continue until the age of 16, as determined by the original drug protocol.

How should Ferriz be stored and disposed of?

How to Store and Dispose of Ferriz?

This section outlines the official, regulator-defined requirements for storing, protecting, and disposing of Ferriz (deferiprone), as documented in governmental sources.

Storage Requirement Official Regulatory Condition
Temperature Store at Controlled Room Temperature: 20 C to 25 C (68 F to 77 F). Excursions permitted up to 30 C (86 F).
Light Protection Keep the medicine in its original container and carton to protect it from light.
Stability (Oral Solution) The oral solution must be used or discarded within 35 days after the bottle is first opened.
Handling Always store the medicine only in the original container.

Official labeling requires strict adherence to these temperature and packaging constraints to maintain the medicine's stability. For the oral solution, disposal rules are based on a defined in-use stability period of 35 days, after which any remaining medicine must be discarded.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ferriz found in:

A-Z Index: